SCHEMBL8562276

SCHEMBL8562276

Clc1ccc(-c2cnc3cnccc3n2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.47
KDM4E B2RXH2 4/20 0.43
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CSNK2B P67870 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
GAA P10253 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 1/20 0.38
CASP1 P29466 1/20 0.38
MAPK10 P53779 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8501924 0.80 PIK3CA (0.43) CYP2A6KDM4EPDGFRBPDGFRAALDH1A1
SCHEMBL8502771 0.77 PIK3CA (0.43) CYP2A6KDM4EPDGFRBPDGFRAALDH1A1
SCHEMBL8499783 0.76 ALDH1A1 (0.39) CYP2A6KDM4EPDGFRBPDGFRAALDH1A1
SCHEMBL8503319 0.74 KDM4E (0.71) CYP2A6KDM4EPDGFRBPDGFRAALDH1A1
SCHEMBL8500059 0.74 NPC1 (0.40) KDM4EPDGFRBPDGFRAALDH1A1MAPT
SCHEMBL8566324 0.73 BCHE (0.48) CYP2A6KDM4EPDGFRBPDGFRAALDH1A1
SCHEMBL8887646 0.72 NPC1 (0.56) CYP2A6KDM4EPDGFRBPDGFRAALDH1A1
SCHEMBL23143410 0.72 MAPK1 (0.54) PDGFRBPDGFRAADORA3SMN1; SMN2NPC1
SCHEMBL21591641 0.71 ALDH1A1 (0.45) CYP2A6KDM4EPDGFRBPDGFRAALDH1A1
SCHEMBL8500901 0.71 PDGFRB (0.71) KDM4EPDGFRBPDGFRAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed